Recursion CEO Chris Gibson on Accelerating the Biopharmaceutical Industry With AI - Ep. 230

Techbio is a field combining data, technology and biology to enhance scientific processes — and AI has the potential to supercharge the biopharmaceutical industry further. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Chris Gibson, cofounder and CEO of Recursion, about how the company uses AI and machine learning to accelerate drug discovery and development at scale. Tune in to hear Gibson discuss how AI is transforming the biopharmaceutical industry by increasing efficiency and lowering discovery costs.

Om Podcasten

One person, one interview, one story. Join us as we explore the impact of AI on our world, one amazing person at a time -- from the wildlife biologist tracking endangered rhinos across the savannah here on Earth to astrophysicists analyzing 10 billion-year-old starlight in distant galaxies to the Walmart data scientist grappling with the hundreds of millions of parameters lurking in the retailer’s supply chain. Every two weeks, we’ll bring you another tale, another 25-minute interview, as we build a real-time oral history of AI that’s already garnered nearly 3.4 million listens and been acclaimed as one of the best AI and machine learning podcasts. Listen in and get inspired. https://blogs.nvidia.com/ai-podcast/